A flow cytometric assay of murine erythrocyte osmotic fragility
Open Access
- 22 April 2026
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (4) , e0345170
Abstract
Flow cytometric test of erythrocyte osmotic fragility (EOF) is a critical diagnostic tool for evaluating membrane stability in hemolytic disorders and storage lesions of human erythrocytes. However, there is a lack of such protocols tailored for mice, one of the most widely used preclinical animal models. In this work, we developed and optimized a flow cytometric assay of murine EOF, which achieved results comparable to the conventional osmotic fragility test. We also validated the protocol by detecting membrane instability of murine erythrocytes induced by Ca² ⁺ -treatment, long-term storage, and phenylhydrazine (PHZ)-induced acute anemia, respectively. Our results showed that Ca² ⁺ -treatment impaired membrane integrity of mouse erythrocytes, resulting in reduced percentage of residual cells compared to the untreated ones (46.5 ± 9.5% vs 79.6 ± 5.3%, P < 0.0001). We found that murine erythrocytes can be stored in 1 x PBS containing 2% FBS at 4°C for one week with intact membrane stability (81.6 ± 4.6% of residual cells vs 82.1 ± 6.0% for the fresh samples, p > 0.05). In PHZ induced anemia model, significant hemolysis was observed at day 3 post injection. In conclusion, our flow cytometric assay of murine EOF is a powerful high-throughput assay for mouse models of membrane disorders, and holds substantial scientific and translational value for investigating pathoetiological mechanisms and developing therapeutic interventions.Keywords
Funding Information
- Experimental Animal Research Fund, and Science and Technology Commission of Shanghai Municipality (22140900100)
This publication has 41 references indexed in Scilit:
- Comparison of a modified flow cytometry osmotic fragility test with the classical method for the diagnosis of hereditary spherocytosisCytometry Part B: Clinical Cytometry, 2021
- Flow Cytometric Analysis of Erythrocytes Osmotic Fragility in Hereditary Spherocytosis: A Case‐Controlled Study Evaluating the Best Anticoagulant, Sample Pre‐Treatment and NaCl Concentration for Reliable Screening of this Red Blood Cell Membrane DisorderCytometry Part B: Clinical Cytometry, 2018
- Flow cytometric osmotic fragility test: Increased assay sensitivity for clinical application in pediatric hematologyCytometry Part B: Clinical Cytometry, 2017
- Flow cytometric osmotic fragility testing does reflect the clinical severity of hereditary spherocytosisCytometry Part B: Clinical Cytometry, 2013
- Flow cytometric osmotic fragility—An effective screening approach for red cell membranopathiesCytometry Part B: Clinical Cytometry, 2011
- A prospective study to assess the predictive value for hereditary spherocytosis using five laboratory tests (cryohemolysis test, eosin-5′-maleimide flow cytometry, osmotic fragility test, autohemolysis test, and SDS-PAGE) on 50 hereditary spherocytosis families in ArgentinaAnnals of Hematology, 2010
- Flow cytometric detection of erythrocyte osmotic fragilityCytometry Part B: Clinical Cytometry, 2008
- Cryohemolysis for the detection of hereditary spherocytosis: Correlation studies with osmotic fragility and autohemolysisAmerican Journal of Hematology, 1998
- Different sensitivities of rat and human red cells to exogenous Ca2+American Journal of Hematology, 1989
- Calcium ions, drug action and the red cell membranePharmacology & Therapeutics, 1982